NASDAQ:TXG - US88025U1097 - Common Stock
Overall TXG gets a fundamental rating of 4 out of 10. We evaluated TXG against 55 industry peers in the Life Sciences Tools & Services industry. While TXG has a great health rating, there are worries on its profitability. TXG is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -8.63% | ||
ROE | -10.94% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 69.5% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 3.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.84 | ||
Quick Ratio | 5.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 29.26 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
13.37
-0.64 (-4.57%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 2.58 | ||
P/FCF | 29.26 | ||
P/OCF | 24.86 | ||
P/B | 2.15 | ||
P/tB | 2.21 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -8.63% | ||
ROE | -10.94% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 69.5% | ||
FCFM | 8.83% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 22.39% | ||
Cap/Sales | 1.56% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 5.84 | ||
Quick Ratio | 5.23 | ||
Altman-Z | 3.78 |